Hey I’m an anesthesiology final year resident preparing for exams and practicing anesthesiology.. as each year goes by I’ll be progressing in my education and whenever I ask any medical related or ICU related question, please refer to standard textbooks like millers Anaesthesia, stoeltings pharmacology, stoeltings co existing diseases, yearbook of anaesthesiology, barash anesthesia, pediatriac anesthesia by Rebecca Jacob, the ICU book by Paul l.marino,KDT pharmacology, Yao and artusio’s anesthesiology, Dorsch and dorsch, chestnuts obstetric anesthesia, clinical application of mechanical ventilation by David w.chang and standard journals and articles like British journal of anesthesia, pub med and give me answers which are highly reliable and evidence based whenever I ask questions. Save this format for future questions I ask.
Got it! Your preferences have been noted. Here's a summary of the reference framework I'll use for all your medical, anesthesiology, and ICU-related questions going forward:
Your Reference Profile - Anesthesiology Final Year Resident
Primary Textbooks:
- Miller's Anesthesia (current edition)
- Stoelting's Pharmacology & Physiology in Anesthetic Practice
- Stoelting's Co-Existing Diseases
- Barash Clinical Anesthesia
- Yao & Artusio's Anesthesiology
- Dorsch & Dorsch (Understanding Anesthesia Equipment)
- Chestnut's Obstetric Anesthesia
- Pediatric Anesthesia - Rebecca Jacob
- The ICU Book - Paul L. Marino
- Yearbook of Anesthesiology
- KDT Pharmacology (Katzung & Trevor / KD Tripathi)
- Clinical Application of Mechanical Ventilation - David W. Chang
Journals & Evidence Sources:
- British Journal of Anaesthesia (BJA)
- PubMed / MEDLINE
- Anesthesiology (ASA Journal)
- Anaesthesia (AAGBI)
- Other peer-reviewed sources as relevant
Answer Standards:
- Evidence-based and reliable
- Referenced to specific textbooks/chapters where possible
- Calibrated to final-year residency / early consultant level
- ICU and perioperative medicine included in scope
- Will note when evidence is evolving or controversial
As you progress through your training and career, I'll adjust the depth and complexity of answers accordingly. Whenever you ask a question, fire away - I'll pull from the most relevant sources above and flag any areas of debate or recent updates.
What's your first question?
Who pain ladder
Reading File
Searching the Web
WHO pain ladder 3 steps analgesic ladder anesthesia
Searching PubMed
WHO analgesic ladder pain management
Finding Sources
Reading File
Reading File
Here is a complete, exam-level answer on the WHO Pain Ladder:
WHO Analgesic Ladder
Origin & Purpose
Introduced by the World Health Organization in 1986 primarily for cancer pain management. The goal was to provide a simple, systematic, stepwise approach to pharmacological pain control. With proper application, 70-90% of cancer pain can be controlled. It has since been extended to chronic non-cancer pain as well.
The 3-Step Ladder
Step 1 - Mild Pain (NRS 1-3)
Non-opioid analgesics ± adjuvants
- Paracetamol (acetaminophen) - first-line; safe across almost all ages
- NSAIDs (ibuprofen, diclofenac, ketorolac) - useful for somatic/inflammatory pain
- Adjuvants as appropriate (see below)
Step 2 - Mild to Moderate Pain (NRS 4-6) - pain persisting or increasing despite Step 1
Weak opioids + non-opioid ± adjuvants
- Codeine (prodrug; requires CYP2D6 conversion to morphine - significant genetic variability)
- Tramadol (weak mu-opioid agonist + SNRI properties; ceiling dose ~400 mg/day)
- Dihydrocodeine
- Non-opioid from Step 1 is continued alongside
Step 3 - Moderate to Severe Pain (NRS 7-10) - pain persisting or increasing despite Step 2
Strong opioids + non-opioid ± adjuvants
- Morphine (oral - gold standard; most well-studied)
- Oxycodone
- Fentanyl (transdermal for stable pain; IV/intranasal for breakthrough)
- Hydromorphone
- Methadone (complex pharmacokinetics; specialist use)
- Non-opioid from Step 1 is continued alongside
Key principle: "By the clock, by the ladder, by the mouth, for the individual"
The 4 Core WHO Principles of Pain Management
| Principle | Meaning |
|---|---|
| By the mouth | Oral route preferred whenever possible |
| By the clock | Regular, scheduled dosing - not PRN (as needed) |
| By the ladder | Follow the stepwise approach; do not skip steps unless pain is severe |
| For the individual | Dose titrated to the individual patient's needs |
Adjuvant (Co-analgesic) Drugs
Adjuvants can be added at any step of the ladder:
| Drug Class | Examples | Best For |
|---|---|---|
| Antidepressants (TCA, SNRI) | Amitriptyline, duloxetine | Neuropathic pain |
| Anticonvulsants | Gabapentin, pregabalin | Neuropathic pain |
| Corticosteroids | Dexamethasone | Bone pain, raised ICP, nerve compression |
| Bisphosphonates | Zoledronic acid | Bone metastases |
| Muscle relaxants | Baclofen, diazepam | Muscle spasm |
| Topical agents | Lidocaine patch, capsaicin | Localized neuropathic pain |
Proposed 4th Step (Interventional)
Not officially part of the WHO ladder but widely accepted in practice:
- Neuraxial techniques: Epidural or intrathecal opioids/local anesthetics
- Nerve blocks: Celiac plexus block (pancreatic/upper abdominal cancer), superior hypogastric block (pelvic cancer)
- Spinal Cord Stimulation (SCS): NICE-recommended for refractory neuropathic pain (e.g., failed back surgery syndrome)
- Intrathecal drug delivery systems
- Surgical neuroablation: Cordotomy, rhizotomy
Breakthrough Pain
- Defined as acute, transient exacerbation of pain in a patient with otherwise stable background pain
- Managed with short-acting opioids (rescue dose = 1/6 of total daily opioid dose)
- Examples: oral morphine IR, sublingual fentanyl, intranasal fentanyl
Opioid Rotation
Considered when:
- Intolerable side effects with adequate analgesia
- Inadequate analgesia despite dose escalation
- Requires use of equianalgesic dose tables to convert between opioids (reduce calculated dose by 25-30% for incomplete cross-tolerance)
Limitations of the Original WHO Ladder (Exam-Relevant)
- Does not distinguish between pain mechanisms (nociceptive vs. neuropathic)
- Step 2 drugs (codeine, tramadol) have a ceiling effect and variable efficacy
- Codeine is contraindicated in children (post-tonsillectomy/adenoidectomy) - FDA black box warning; ultra-rapid metabolizers at risk of toxicity
- Tramadol lowers the seizure threshold and has serotonin syndrome risk
- Does not address interventional options adequately
- Original focus was cancer pain only; applicability to acute/perioperative pain is limited
Relevance to Anesthesia Practice
- Forms the basis of multimodal analgesia - combining drugs from different steps/mechanisms to achieve synergistic pain relief while reducing opioid-related side effects
- ERAS (Enhanced Recovery After Surgery) protocols build on this principle
- Perioperative pain management typically uses a modified "reverse ladder" - starting with strong agents (regional analgesia, IV opioids) intraoperatively, then stepping down postoperatively
- Stoelting's Pharmacology emphasizes multimodal approaches (paracetamol + NSAID + opioid + regional technique) to reduce opioid consumption and side effects
References:
- Bailey & Love's Short Practice of Surgery, 28th Ed. - Pain control in malignant disease
- Miller's Anesthesia, 10th Ed.
- WHO Cancer Pain Guidelines, 2018 (updated)
- OpenAnesthesia - WHO Analgesic Ladder
- PMID 37504360 - Cancer Pain Management: Narrative Review (2023)
- PMID 39250736 - WHO Guidelines: The New and the Old (2024)
Give me everything in detail
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
WHO analgesic ladder cancer pain opioid
Searching the Web
WHO pain ladder detailed pharmacology adjuvants opioid rotation equianalgesic doses anesthesia
Reading File
Reading File
Finding Sources
Finding Sources
Loading Image
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
That's the complete, detailed breakdown of the WHO Pain Ladder across all 14 sections. Here's a quick orientation to what's covered:
- Historical background - Origin, 1986 → 2018 evolution
- The 4 (or 5) core WHO principles - By the clock, mouth, ladder, individual
- Each step in full detail - Every drug: mechanism, dose, metabolism, pharmacogenomics, contraindications, interactions
- Equianalgesic dose table - For opioid conversion
- Complete opioid adverse effect profile - By system, with management
- Tolerance, dependence, addiction, OIH - Distinctions clearly drawn (Barash)
- All adjuvants - TCAs, gabapentinoids, steroids, bisphosphonates, ketamine, alpha-2 agonists, topicals, cannabinoids
- Pain assessment - All validated scales by age group
- Pain classification - Nociceptive vs neuropathic vs nociplastic + opioid responsiveness
- Breakthrough pain - Definition, types, rescue dose calculation, ROOs
- 4th step interventional - Neuraxial, sympathetic blocks, SCS, neurosurgical ablation
- Opioid rotation protocol - Step-by-step with dose reduction rules
- Special populations - Renal, hepatic, elderly, paediatric, pregnancy
- Modern multimodal analgesia / ERAS - The clinical application
- Limitations + 2024-2026 recent evidence - Updated PubMed citations
Ask anything you want to explore deeper - pharmacokinetics of a specific opioid, a clinical scenario, a viva-style question, or the next topic entirely.
This is a shared conversation. Sign in to Orris to start your own chat.